Our US Grantees

anil prasad

Anil Prasad, Ph.D.

Beth Israel Deaconess Medical Center Characterization of Cannabidiol (CBD) as a Novel Therapy for Mantle Cell Lymphoma...more

anthony brickner

Anthony G. Brickner, Ph.D.

University of Pittsburgh Cancer Institute Identifying stop codon-generated minor histocompatibility antigens capable of eliciting potent GVL or GVHD alloresponses...more

anthony letai

Anthony G. Letai, M.D., Ph.D.

Dana-Farber Cancer Institute, Harvard University Detecting blocks in Apoptosis in Leukemia Stem Cells...more


Arash Ash Alizadeh, M.D., Ph.D.

Stanford University School of MedicineProspective Validation and Genetic Basis of a Novel Molecular Risk Predictor for Diffuse large B-Cell Lymphoma...more

ari melnick

Ari M. Melnick, M.D.

Albert Einstein College of Medicine The Bcl-6 oncoprotein as a target for transcription therapy...more


Arnob Banerjee, M.D., Ph.D.

University of Maryland School of MedicineGenomic and Functional Identification of Critical Targets in Peripheral T Cell Lymphoma...more


Benjamin L. Ebert, M.D., Ph.D.*

Dana-Farber Cancer InstituteIdentification of genetic dependencies in leukemia stem cells...more

boglarka gyukorcza

Boglarka Gyurkocza, M.D.

Fred Hutchinson Cancer Research CenterReducing Relapse of Acute Myeloid Leukemia after Hematopoietic Cell Transplantation...more


Boyi Gan, Ph.D.

MD Anderson Cancer CenterStudy Energy Sensing Signaling in Leukemia Stem Cells and Leukemia Development...more

chengcheng zhang

Chengcheng (Alec) Zhang, Ph.D.

University of Texas, Southwestern Ex Vivo expansion of hematopoietic stem cells for cord blood and allogeneic transplantations...more

chuan he

Chuan He, Ph.D.

The University of Chicago Improving the Efficiency of Alkylation Anticancer Chemotherapies...more

Craig Okada, M.D.

Oregon Health & Science University Tumor Antigen Receptor Vaccines for Active Immunotherapy of T Cell Malignancies...more


Daisuke Nakada, PhD

Baylor College of Medicine Metabolic regulation of leukemia stem cells...more


Daniel Starczynowski, Ph.D.

Cincinnati Children's Hospital Defining the role and therapeutic potential of TNF receptor-associated factor 6 in Myelodysplastic Syndromes...more

david frank

David Frank, M.D., Ph.D.

Dana-Farber Cancer Institute The Development of STAT Inhibitors as Novel Anti-Leukemia Agents: Use of Semi-Random Synthesis Technology...more

david sternberg

David W. Sternberg, M.D., Ph.D.

Mount Sinai School of Medicine Translational Regulation of Gene Expression in Acute Myelogenous Leukemia (AML)...more

dawn lemanne

Dawn Lemanne, M.D., MPH

Memorial Sloan-Kettering Cancer CenterA Randomized Trial of Physical-Activity Motivation in Breast Cancer Patients....more


Dorothy Sipkins, M.D., Ph.D.*

The University of ChicagoRegulation of Leukemia Cell Dormancy by the Bone Marrow Microenvironment...more

douglas graham

Douglas K. Graham, M.D., Ph.D.

University of Colorado Health Sciences Center Mer Tyrosine Kinase as a Cooperative Oncogene in Leukemogenesis...more


Eddy Shih-Hsin Yang, M.D., Ph.D.

University of Alabama-Birmingham Comprehensive Cancer Center Mechanisms by which GSK3β inhibition enhances nonhomologous end-joining repair of IR-induced double strand breaks...more